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Abstract: The efficacy of the University of Wisconsin (UW) solution was 
compared with conventional Euro-Collins solution, as well as with 3 vari-
ants of a silica gel solution developed at the University of Minnesota 
(UM). Protection of the liver grafts with UW was superior after 24 hour 
preservation, although the results were inferior to those with immediate 
transplantation, as judged by animal survival, liver function tests, coagu-
lation, and histopathologic parameters. The UM-III solution allowed 
similar animal survival as with the UW solution. Lactobionate and 
raffinose that are contained in both the UW and UM-III solutions were 
thought to be essential constituents for long-term preservation of liver 
grafts. The study not only establishes, under controlled circumstances, 
the superiority of the UW solution, but it also provides insight about the 
reasons for its effectiveness as well as a caution against its over exploi-
tation. 
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Jamieson (1) and Kalayoglu (2) have described 
improved liver preservation in dogs and humans 
after cold infusion and "slush" refrigeration of 
hepatic grafts using a solution developed at the 
University of Wisconsin (UW). These claims have 
been supported by the results of a large clinical 
trial in our center (3-5) in which nearly 400 human 
liver grafts were preserved with UW solution for 
periods up to 35 h. 
Before embarking on this clinical trial, we car-
ried out preliminary experiments in dogs during 
October and November, 1987. We demonstrated 
that 24-h preservation of the canine liver with the 
UW solution could be achieved more reliably than 
with Euro-Collins solution, but that the results 
were not as good as with transplantation immedi-
ately after cooling with lactated Ringer's solution. 
These inquiries have grown into a formal compari-
son of several solutions that are commercially 
available or under development for preservation of 
the liver or other organs. 
Supported by Research Grants from the Veterans Adminis-
tration, Project Grant No. OK 29961 from the National Insti-
tutes of Health, Bethesda, Maryland, and the Pathology Edu-
cation and Research Foundation, Pittsburgh, Pennsylvania. 
Material and methods 
Animals 
Inbred beagle dogs weighing 10 to 15 kg were 
purchased from the University farm and were star-
ved from the evening before the operation. Donors 
were slightly smaller than the recipients. Anesthesia 
was induced with 25 mg/kg thiopental intra-
venously. Maintenance of anesthesia while on 
mechanical ventilation was by the intravenous in-
jection of 2 mg/kg ketamine and 0.5 mg pancuron-
ium every 30 to 60 min. Electrocardiogram, arterial 
pressure, central venous pressure, and esophageal 
temperature were monitored. 
Surgical procedures 
Donor operation: Procurement of hepatic homo-
graft and orthotopic liver transplantation in dogs 
were performed by the method described before 
(6), with minor modifications. Through a midline 
incision, the abdominal aorta from the diaphragm 
to the iliac bifurcation was isolated, leaving the 
celiac axis and the superior mesenteric artery in-
tact. After incision of the fundus of the gallbladder, 
the common bile duct and the gastroduodenal ar-
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tery were transected near the duodenum. The por-
tal vein was cleaned off to the confluence of the 
superior mesenteric vein and the splenic vein into 
which a cannula for the infusion of cooling fluids 
was inserted. The distal aorta was cannulated for 
subsequent collection of 2 units of blood for trans-
fusion. After ligating the superior mesenteric artery 
and vein, infusion and cooling of the liver was 
commenced through the cannula in the splenic vein 
with 1300 ml of cold lactated Ringer's solution at 
a hydrostatic pressure of 100 cm, and the dog 
was exsanguinated simultaneously into the blood 
collection bags. At the end of the infusion, the liver 
was rapidly skeletonized, isolated, and removed en 
bloc. The liver was then placed in the basin filled 
with cold lactated Ringer's solution and cleaned 
carefully, leaving enough vessel length for anasto-
moses. The liver was finally perfused on the back 
table with cold preservation fluids, 700 ml through 
the portal vein and 300 ml through the abdominal 
aorta, weighed, packed in a plastic bag and stored 
in an ice-box until transplantation. 
Recipient operation 
Through a midline incision, the abdominal aorta 
below the left renal vein was dissected for eventual 
arterial reconstruction. The hepatic arteries and 
biliary ducts of the host liver were divided and 
ligated high in the liver hilum. All of the hepatic 
ligaments were divided. Three by-pass tubings were 
inserted into the external jugular vein, the femoral 
vein and the splenic vein and the animal was placed 
on the veno-venous by-pass (7). The portal vein, 
the infra-hepatic vena cava and the supra-hepatic 
vena cava were cross-clamped and the host liver 
was removed. 
The vascular anastomoses of the graft were with 
continuous sutures of the supra-hepatic vena cava, 
the portal vein, the infra-hepatic vena cava, and 
the abdominal aorta, in this order. After the supra-
hepatic vena cava was anastomosed, the graft was 
flushed with 200 ml of cold lactated Ringer's solu-
tion. The liver was revascularized immediately after 
the portal vein was anastomosed, which was then 
followed by anastomosis of the infra-hepatic vena 
cava. Reconstruction of the hepatic arterial flow 
was with an end-to-side aorta-to-aorta anasto-
mosis. Biliary reconstruction was with cholecysto-
duodenostomy, and splenectomy was carried out 
eventually. 
Blood gas and electrolytes were frequently moni-
tored, and abnormalities were corrected with cal-
cium chloride, potassium chloride and sodium bi-
carbonate, if necessary. Low-dose dopamine was 
given in most cases during and after the by-pass 
period. Approximately 2 to 3 units electrolyte solu-
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tion (Plasmalyte®) were given during the operation. 
The amount of blood transfusion was restricted to 
5 units (2500 ml) even though bleeding continued. 
Three units of blood collected from a blood donor 
dog on the morning of operation were started at 
the time of graft reperfusion, and the other 2 units 
which had been collected from the liver donor were 
given later. 
Animal conditions, electrolytes, blood gas and 
fluid maintenance were observed for the first 24 h 
after the transplant, but no glucose or albumin 
were given. One gram of cephalosporin was ad-
ministered during the operation and daily there-
after for 5 d. Animals were allowed to eat from 
the next morning and 20 mg/kg of oral cyclospo-
rine was given every morning. 
Experimental groups 
Six different preservation fluids were tested with 
seven experimental groups, involving 45 liver trans-
plantations. For immediate transplantation, lac-
tated Ringer's solution (Group l/LR, n= 10) and 
UW solution (Group 2/UW, n = 5) were used. 
Fluids used for 24-h preservation were Euro-Col-
Table 1. Characteristics and constituents of test solutions 
EC LR UW UM1 UM2 UM3 
Anions 
Bicarbonate m Mil 10 
Chloride mM/1 15 109 20 5 
Lactate ITI Mil 28 
Phosphate mM/1 57.5 25 0.72 
Lactobionate m Mil 100 90 
Cations 
Calcium mM/1 1.5 0.6-1.4 
Sodium mM/1 10 130 30 146 146 1 
Potassium mM/1 115 4 120 4.3 24.3 124 
Magnesium m/M/1 5 4 7.8 
Colloids and Osmotically Active Agents 
Hydroxy ethyl starch gil 50 
Proteins gil 65.2 90 65 
Mannitol gil 3.75 
Raffinose gil 17.8 48 
Glucose gil 194 99 
Others 
Adenosine gil 1.34 
Glutathione gil 0.922 
Insulin Units 100 
Allopurinol gil 0.136 
Antibiotics/Steroids 
Ampicillin mg 250 50 
Sulfamethoxazole mg 40 
Trimethoprim mg 8 
Dexamethasone mg 8 
Methyl Prednisolone mg 250 500 
Osmolality (mosm/l) 375 273 320 308 301 
PH 7.4 6.3 7.4 7.4 7.4 7.4 
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Fig. 1. Animal survival after transplantation of liver grafts 
preserved with various test solutions. 
lins solution (Group 3/EC, n = 5), UW solution 
(Group 4/UW, n= 10), UM-I solution (Group 5/ 
UM-I, n= 5), UM-II solution (Group 6/UM-II, 
n=3), and UM-III solution (Group 7/UM-III, n= 
7). Lactated Ringers (Abbott Laboratories, North 
Chicago, IL) and Euro-Collins (Fresenius Ag, Bad 
Homburg, West Germany) solutions were pur-
chased commercially, and UW solution was sup-
plied from the DuPont Corporation, Waukegan, 
Illinois. All of UM solutions were sent from the 
University of Minnesota, Department of Surgery, 
MALG program, Minneapolis, Minnesota. Key 
contents and physiological characteristics of these 
fluids are listed in Table 1. 
Evaluation 
Graft weight change, occurrence of hypotension or 
outflow block after reperfusion, and amount of 
transfusion were determined during the operation. 
Standard liver function measurements after trans-
plantation included aspartate aminotransferase 
(AST), alanine aminotransferase (ALT) , total bili-
rubin, glucose, and prothrombin time CPT). Coagu-
lation profiles were monitored by thromboelasto-
gram (TEG) in most animals during the operation. 
Canine liver preservation 
Liver biopsies for histopathologic study were taken 
at the beginning and at the end of the 24-h preser-
vation, and at 3 h after graft reperfusion. Complete 
postmortem examinations were performed on all 
of animals that died. Tissues were fixed in 10% 
formalin and stained with Hematoxylin-Eosin. 
Histopathologic analyses were carried out blindly, 
without foreknowledge of the experimental group 
from which the tissues were obtained. 
Statistics 
Values were expressed as mean ± standard devi-
ation (SD). Group comparisons were performed 
by Student's t-test and Mann Whitney U test. 
Results 
Survival 
Differences in animal survival after liver transplan-
tation of all experimental groups are shown in Fig. 
1. When transplantation was performed immedi-
ately after flushing with either LR (Group 1) or 
UW (Group 2), 80% of each group lived for more 
than 7 d. Two animals in Group 1 and 1 animal in 
Group 2 died of pulmonary edema between 12 h 
and 24 h post-Tx. When grafts were preserved for 
24 h, only 3 animals out of lOin the UW Group 
4 (30%) and 3 animals out of 7 in the UM-IIT 
Group 7 (43%) lived for more than 7 d. In ad-
dition, all animals receiving 24-h livers preserved 
with EC (Group 3), UM-I (Group 5), and UM-IT 
(Group 6) died intraoperatively or within 12 h after 
graft revascularization. Lethal bleeding and/or car-
diac arrest were the main causes of the deaths that 
occurred in less than 12 h. Nine of the 12 animals 
that died between 12 and 24 h had pulmonary 
edema, reflecting the fluid resuscitation attempts 
in these animals which had escaped earlier death 
from bleeding or cardiac arrest (Table 2). 
Of the animals that lived for more than 7 dafter 
the operation, 2 dogs in Group 1 (25%) and all 3 
dogs in Group 4 lived for more than 3 months with 
Table 2. Duration of cold ischemia time and cause of animal death after liver transplantation in dogs 
Animals Lived for more 
Cause of Animal Death (h) 
Groups Solution n Cold Ischemia Time (h) than 7 d Bleeding Arrest Pulmonary Edema 
1 LR 10 1.84 ± 0.32 8 12,12 
2 UW 5 2.28± 0.38 4 24 
3 EC 5 25.75± 0.78 0 1.5,3,6,6,12 
4 UW 10 25.17 ± 1.14 3 3,17 12,12,23,24,48 
5 UM-1 5 25.56 ± 0.78 0 6,6,8 1,1 
6 UM-2 3 24.79 ± 0.74 0 6,6,12 
7 UM-3 7 25.42 ± 0.74 3 10,11 0.5 18 
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normal graft function. Three animals in Group 2 
(75%) and 2 animals in Group 7 (67%) are still 
alive in good condition after more than 2 months. 
Graft weight change 
All the livers that were preserved with EC for 24 
h gained weight, average 5% and ranging from 
2.9% to 20% (Fig. 2). When UW was used, all 
grafts except one lost graft weight, averaging 
-10.7% and ranging from 6.6% to -16.0%. Av-
erage graft weights in 3 UM groups diminished 
slightly (Fig. 2). 
Intraoperative findings 
Immediate and homogeneous perfusion was in-
variable in Group I and Group 2 grafts when the 
portal clamp was released. There was no incidence 
of outflow block in these animals. Even after 24 h 
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Fig. 2. Graft weight change, amount of blood transfusion and 
graft function at 1 h after graft revascularization. 
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of preservation, re-perfusion of Group 4 grafts was 
as good as that in Group 1 and Group 2, but there 
appeared to be a moderate outflow block for the 
next 2 to 3 h. Disturbance of reperfusion and oc-
currence of outflow block was most striking in 
grafts from Groups 3, 5, and 6. These animals 
always developed profound hypotension immedi-
ately after graft revascularization with a need for 
rapid infusion and dopamine. Findings with Group 
7 grafts were intermediate, but with less outflow 
block than Group 4. 
Graft function 
The majority of the animals that received 24-h 
preserved grafts died between 3 and 6 h postopera-
tively. Consequently, studies of graft function 1 h 
after graft reperfusion were the most complete for 
purposes of intergroup comparison (Fig. 2). Fig. 3 
shows the postoperative changes of AST and total 
bilirubin in culled animals that lived for more than 
7 d. 
Although cold ischemia time was usually less 
than 1 h in control groups 1 and 2, there was an 
elevation of liver enzymes and blood glucose (Fig. 
2). These rises were slighter after the use of UW 
than with LR. The subsequent changes in the short 
ischemia dogs that lived for at least 7 d were less 
severe and normalized faster with UW (Group 2) 
than lactated Ringer (Group 1) livers (Fig. 3). 
After 24 h of preservation, the liver damage 1 
h after re-perfusion was worst in the EC group, 
intermediate in the 3 UM groups, and least in the 
UW group (Fig. 2). The UW animals which lived 
for a week had better postoperative graft function 
and quicker recovery than the livers preserved with 
UM-3 (Fig. 3). 
Amount of transfusion 
Quality of preserved grafts was reflected in the 
amount of blood given to/the animals. All of the 
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than 7 d after liver transplantation. 
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Canine liver preservation 
Table 3. Differences in coagulation profiles of animals at 30 min after graft revascularization 
Immediate OLTx 
Variable Control LR 
Reaction time (min) 5.8±2.7 5.5±1.7 
Coagulation time (min) 10.0±3.3 9.8±3.3 
Clot formation (0) 48.2± 18.3 47.5± 13.6 
Prothrombin time (sec) 7.5±0.2 8.5±0.4 
Platelet count (1000/mm 3) 238± 89 245±143 
immediate liver transplantations were ac-
complished with less than 2 units of blood and, of 
these, the UW animals required significantly less 
blood than those with LR (Fig. 2). In contrast, all 
of the animals that received 24-h grafts needed 
more than 2 units blood transfusion, except for 2 
animals in group 4 (UW) and 1 animal in group 7 
(UM-III). Blood requirement of UW and UM-3 
animals was significantly smaller than the other 
group animals. 
Coagulation 
Group I animals showed no important changes in 
TEG measures and platelet counts throughout the 
operation, but PT at 30 min after graft revascul-
arization was slightly but significantly prolonged 
(Table 3). When grafts were preserved for 24 h, 
coagulopathy was most striking in EC animals, 
with prolonged coagulation time and PT, poor clot 
formation and diminished platelet counts. TEO 
abnormalities were variable among group 4, group 
5 and group 7 animals, but UW animals showed 
significantly better PT and higher platelet counts. 
Pathology 
Histopathologic changes most frequently encoun-
tered in liver biopsy specimens included varying 
degrees of portal edema/hemorrhage, vacuoliz-
ation of hepatocyte cytoplasm, neutrophilic infil-
tration of the sinusoids, and necrosis. 
Baseline biopsies at the beginning of preser-
vation showed no necrosis in any of these speci-
mens. Any other alterations were minor-to-absent, 
with no observable differences among groups. Bi-
opsies taken after 24 h of preservation, but before 
transplantation, showed increases in portal edema 
and hepatocyte vacuolization when compared to 
biopsies taken from Group 2 animals. 
Another series of biopsies was taken at 3 h after 
transplantation. Livers preserved for 24 h before 
transplantation showed a greater degree of neutro-
philic infiltration of sinusoids in comparison to 
Group I and Group 2 animals. In addition, areas 
of spotty hepatocyte necrosis were observed in all 
24-hr OLTx 
EC UW UM-1 UM-3 
13.5 ± 2.1 10.3±4.4 7.5±0.7 6.3±3.5 
29.5±0.7 18.8±6.6 14.0±0.0 16.6 ± 5.5 
17.5± 0.5 30.8±7.7 40.0±0.O 38.6± 6.6 
26.6± 13.2 10.6±O.6 18.3±2.5 13.1 ±4.1 
91.3±46.2 128± 29 47±15 77±45 
24-h preservation Groups but not in immediate 
transplant groups. 
Among the groups transplanted after 24-h liver 
preservation, little objective differences could be 
discerned at the 3-h post-transplant mark. Group 
4 displayed somewhat less neutrophilic infiltration 
and contained less necrosis than Groups 3, 5, 6, or 
7. Conversely, vacuolar changes were less promi-
nent in specimens from Group 5 and 7 animals. 
Discussion 
Steps in the development ofliver graft preservation 
have been few in number. However, the principles 
involved have been applicable for the preservation 
of other whole organs. The first innovation of core 
cooling by. infusion of chilled lactated Ringer's 
solution into the portal vein may have been the 
most important (8, 9). Before this time, survival of 
dogs after' liver transplantation was almost never 
obtained, but afterwards success became almost 
routine (8). Earlier, it had been appreciated by 
cardiac surgeons that hypothermia protected ische-
mic tissue below the level of aortic-clamping (10), 
a concept which was applied by Lillehei et al. (11) 
with simple immersion of intestine in iced saline 
before its autotransplantation. The concept was 
quantified by Sicular and Moore (12) who reported 
a slowed rate of enzyme degradation in cold hepa-
tic slices. 
Hypothermia to protect human renal homo-
grafts was first accomplished with total body hypo-
thermia of living volunteer donors (13), but before 
long the same teams which had learned the value 
of hepatic core cooling replaced this cumbersome 
and potentially dangerous method with infusion of 
chilled fluid into the kidney immediately after its 
removal (14). Today, core cooling is the first step 
in the preservation of all whole organ grafts and 
this is most often done in situ by some variant of 
the technique described by Marchioro et al. (15). 
This method for the continuous hypothermic per-
fusion of cadaveric livers and kidneys was used 
clinically long before the acceptance of brain death 
conditions. Ackerman and Snell (16) and Merkel, 
Jonasson and Bergan (17) popularized in situ cool-
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ing of cadaveric kidneys with cold electrolyte solu-
tions infused into the distal aorta. An extension of 
this technique has allowed removal of all thoracic 
and abdominal organs, including the liver, without 
jeopardizing any of the individual organs (18). 
Extension of the safe period beyond that pro-
vided by initial cooling has followed one of two 
prototype strategies, in research which was done 
mainly with kidneys and applied secondarily to 
livers. One approach was to provide a limited and 
continuous renal arterial circulation as was done 
by Ackerman and Barnard (19) with a perfusate 
that was primed with blood and oxygenated within 
a hyperbaric oxygen chamber. The same method 
with slight modifications also permitted the suc-
cessful preservation of dog livers for as long as 2 
d (20), and was applied clinically with remarkable 
success in several human cases in the pre-brain 
death era (21). When Belzer et al. (22) were able to 
eliminate the hemoglobin and hyperbaric chamber 
components for kidney preservation, their asangu-
inous perfusion technique became a worldwide 
standard. However, efforts to use this modification 
for livers were unsuccessful (23). 
The alternative strategy for the preservation of 
kidneys, livers, and other organs has been the instil-
lation of special solutions such as that described 
by Collins, Bravo-Shugarman and Terasaki (24) or 
the plasma-like Schalm solution (25). The original 
Collins solution, or modifications of it, has been 
used for almost 2 decades for the so-called "slush" 
techniques of kidney preservation. The experimen-
tal work of Benichou et al. (26) and Wall et al. (27) 
with the Collins and Schalm solutions preceded 
their first clinical use for livers in 1976 which open-
ed up the possibility of organ sharing between 
cities, but within narrow time limitations. The in-
troduction of the UW solution has been the first 
major development in liver preservation since then. 
The superiority of the UW -solution to any of 
previous conventional solutions for preservation of 
liver and extrahepatic organs has been demon-
strated in experimental test models (1, 28-32) and 
confirmed in clinical trials (2-5, 33). In our trials 
(3-5), the UW livers performed better even though 
they were preserved on the average for almost twice 
as long as the EC livers. The UW livers permitted 
a higher rate of graft survival, and they had a 
lower rate of primary non-function, hepatic artery 
thrombosis and retransplantation. 
The present experiment, which was initially de-
signed to evaluate the UW solution in a preclinical 
study, grew to a formal comparison of several solu-
tions that are commercially available (LR and EC) 
or under development for kidney (UM-I), pancreas 
(UM-II), and liver (UM-III) preservation. The re-
sults showed that the UW solution provided su-
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perior protection of liver grafts, not only for 24-h 
preservation but also with immediate transplan-
tation. The UM-III solution allowed even better 
animal survival after 24 h of liver preservation, 
although the protection as judged by graft function 
may not have been quite as good. 
These animal studies may restore a logical per-
spective about the importance of storage time. The 
results of the clinical trials with the UW solution 
(2-5) have been so good that it looked as if the 
duration of cold ischemia was irrelevant. The con-
trolled animal experiments have made it obvious 
that this is not true. In the difficult dog model, 
time of ischemia has been shown once more to be 
of the utmost importance. Transplantation of a 
fresh liver provided the best results either when the 
initial chilling was with LR solution or especially 
with UW solution. After preservation for 24 h, by 
which time in humans no deterioration in cadaveric 
grafts could be detected (2-5), the results in dogs 
had degraded to the point that only a minority of 
animals lived beyond the 1st post-operative wk. 
The same was true for the UM-III grafts. In every 
animal, the procedure had gone well, but most of 
the grafts had demonstrable dysfunction. Many 
of the recipients suffered from various degrees of 
outflow block, coagulopathy, and other manifes-
tations of ischemic liver injury. The results were 
not as good as those reported by Jamieson et al. 
(1) who had no animal deaths due to liver failure 
after up to 30 h or more preservation with UW. 
Whatever the limitations of cold storage may 
prove to be, the advantages of the UW solution 
are so obvious from the present study and from 
the clinical series (2-5), that an explanation for 
its efficacy will be sought. The rationale for the 
UW solution has been provided by Belzer and 
Southard (33). The UW solution contains more 
than 10 ingredients. Important components and 
their effects are: lactobionate and raffinose to 
prevent cell swelling, hydroxyethyl starch to sup-
port colloidal pressure, allopurinol and glutathio-
ne to inhibit oxygen free radical generation, and 
adenosine to enhance ATP synthesis after reper-
fusion (33). In our studies, the differences in the 
performance of the solutions tested may provide 
sketchy insight into the relative importance of 
some constituents. It is clear that an intracellular-
like electrolyte solution (EC), or a hyperosmolar 
colloid solution (UM-I and UM-II) are not 
enough for long-term cold storage of the liver, 
even though these can be useful for extrahepatic 
organs (34, 35). Lactobionate and raffinose could 
be the most essential ingredients since they were 
common features of the best solutions, namely 
the UW solution and the UM-III preparation. 
The UM-III was the otherwise ineffective UM-
I, supplemented only with these two ingredients. 
Contribution of other constituents in the UW 
solution for successful liver preservation is under 
investigation using different experimental models. 
The weight gain that is common in organs pre-
served by past flush techniques was avoided by 
the use of both the UW and UM-III solutions, 
something previously emphasized when the UW 
was used for preservation by Wahlberg et al. (28). 
Undoubtedly, fuller understanding of the action of 
UW will be a touchstone for more refinements, 
including a renewal of interest in the continuous 
asanguinous perfusion techniques pioneered by the 
same Wisconsin research team (36). 
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